Home/Filings/4/0001593968-24-000434
4//SEC Filing

Davis Andrew S. 4

Accession 0001593968-24-000434

CIK 0001397702other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 6:25 PM ET

Size

6.7 KB

Accession

0001593968-24-000434

Insider Transaction Report

Form 4
Period: 2024-03-01
Davis Andrew S.
EVP Global Sales & Marketing
Transactions
  • Award

    Common Stock

    2024-03-01+62,201293,254 total
  • Sale

    Common Stock

    2024-03-05$17.17/sh5,481$94,103287,773 total
Footnotes (2)
  • [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
  • [F2]Represents shares that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

Issuer

Silk Road Medical Inc

CIK 0001397702

Entity typeother

Related Parties

1
  • filerCIK 0001770191

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:25 PM ET
Size
6.7 KB